Inloggen
E-mail
Wachtwoord
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. AustraliŽ
  4. Australian Stock Exchange
  5. Clinuvel Pharmaceuticals Limited
  6. Nieuws
  7. Andere talen
    CUV   AU000000CUV3

CLINUVEL PHARMACEUTICALS LIMITED

(CUV)
OverzichtGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningen 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op CLINUVEL PHARMACEUTICALS LIMITED
30/07CLINUVEL PHARMACEUTICALS : Books $11 Million Cash Receipts in Fiscal Q4
07/06CLINUVEL PHARMACEUTICALS : Treats First Patient in Phase 2 Study of Stroke Drug;..
07/06CLINUVEL PHARMACEUTICALS : Media release - First stroke patient with afamelanoti..
07/06CLINUVEL PHARMACEUTICALS : First stroke patient treated with afamelanotide
07/06Clinuvel Pharmaceuticals Limited Announces First Stroke Patient Treated with ..
04/06CLINUVEL PHARMACEUTICALS : Presentation to Jefferies Healthcare Conference
03/06CLINUVEL PHARMACEUTICALS : Newsletter 3 - June 2021
29/04CLINUVEL PHARMACEUTICALS : Appendix 4C - quarterly
12/04CLINUVEL PHARMACEUTICALS : Strategic Update II - April 2021
01/04CLINUVEL PHARMACEUTICALS : Newsletter II - April 2021
24/03CLINUVEL PHARMACEUTICALS : Media Release - CLINUVEL expands DNA Repair Program
24/03CLINUVEL PHARMACEUTICALS : SCENESSE to be assessed in xeroderma pigmentosum vari..
24/03CLINUVEL expands DNA Repair Program
24/03CLINUVEL Expands DNA Repair Program
10/03CLINUVEL PHARMACEUTICALS : Presentation - Daiwa Investment Conference Tokyo 2021
01/03Australia shares climb 1.5% as country inches towards pre-pandemic normal
25/02CLINUVEL PHARMACEUTICALS : Operations Update Webinar Released
24/02CLINUVEL PHARMACEUTICALS : Reports Tenth Consecutive Half Year Profit
24/02CLINUVEL PHARMACEUTICALS : Appendix 4D Half Yearly Report
24/02Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Half Year E..
11/02CLINUVEL PHARMACEUTICALS' : Light Toxicity Treatment Receives Market Access Appr..
10/02CLINUVEL PHARMACEUTICALS : SCENESSE Granted Market Access in Israel
27/01CLINUVEL PHARMACEUTICALS : Appendix 4C - quarterly
24/01CLINUVEL PHARMACEUTICALS : Newsletter
2020CLINUVEL PHARMACEUTICALS : Appendix 3G
2020CLINUVEL PHARMACEUTICALS : Newsletter
2020CLINUVEL PHARMACEUTICALS : SCENESSE DNA Repair Study Approved to Commence
2020Clinuvel Pharmaceuticals Limited Receives Approval to Commence a New Study As..
2020CLINUVEL PHARMACEUTICALS : Presentation Jefferies Virtual London Healthcare Conf..
2020CLINUVEL PHARMACEUTICALS : Chair Letter
2020CLINUVEL PHARMACEUTICALS : Results of Meeting
2020CLINUVEL PHARMACEUTICALS : Chair Address
2020CLINUVEL PHARMACEUTICALS : Managing Directors AGM Presentation
2020CLINUVEL PHARMACEUTICALS : Strategic Update - Executive Summary
2020CLINUVEL PHARMACEUTICALS : Strategic Update - Extended
2020CLINUVEL PHARMACEUTICALS : Strategic Update – Executive Summary
2020CLINUVEL PHARMACEUTICALS : Appendix 4C - quarterly
2020CLINUVEL PHARMACEUTICALS : to Trial Innovative Drug in Stroke
2020CLINUVEL to Trial Innovative Drug in Stroke
2020CLINUVEL to Trial Innovative Drug in Stroke
2020CLINUVEL PHARMACEUTICALS : Media Release - CLINUVEL to Trial Innovative Drug in ..
2020CLINUVEL PHARMACEUTICALS : afamelanotide for Acute Stroke Patients
2020Clinuvel Pharmaceuticals Limited Announces Evaluation the Effects of Its Drug..
2020CLINUVEL PHARMACEUTICALS : Media Release - TGA approves SCENESSE
2020CLINUVEL PHARMACEUTICALS : Australian TGA approves SCENESSE
2020Clinuvel Pharmaceuticals Limited Receives Approval in Australia for a Rare Li..
2020CLINUVEL PHARMACEUTICALS : SCENESSE DNA Repair Update
2020Clinuvel Pharmaceuticals Limited Announces Clinical Update on the Use of Its ..
2020CLINUVEL PHARMACEUTICALS : Further Research Coverage Initiated on CLINUVEL
2020CLINUVEL PHARMACEUTICALS : Presentation - Value in the Vines Investor Conference
2020CLINUVEL PHARMACEUTICALS : Annual General Meeting 2020
2020CLINUVEL PHARMACEUTICALS : Appendix 4G and Corporate Governance Statement
2020CLINUVEL PHARMACEUTICALS : Annual Report to shareholders
2020CLINUVEL PHARMACEUTICALS : Confirms AGM Date
2020Australia shares slip as virus cases resurge in Europe; NZ lower
2020First patient dosed in SCENESSEģ DNA Repair Program
2020CLINUVEL PHARMACEUTICALS : First patient dosed in SCENESSEģ DNA Repair Program
2020CLINUVEL PHARMACEUTICALS : Media Release - First patient dosed in SCENESSE DNA R..
2020CLINUVEL PHARMACEUTICALS : First patient dosed in SCENESSE DNA Repair Program
2020Clinuvel Pharmaceuticals Limited Announces First Patient Dosed in SCENESSE DN..
2020CLINUVEL progresses innovative DNA Repair Program
2020CLINUVEL PHARMACEUTICALS : progresses innovative DNA Repair Program
2020CLINUVEL PHARMACEUTICALS : progresses innovative DNA Repair Program
2020Clinuvel Pharmaceuticals Limited Progresses Innovative DNA Repair Program
2020CLINUVEL PHARMACEUTICALS : SCENESSE in DNA Repair
2020CLINUVEL Opens VALLAURIX R&D Centre In Singapore
2020Clinuvel Pharmaceuticals Limited Announces Opening of Vallaurix R&D Facilitie..
2020CLINUVEL PHARMACEUTICALS : Corporate Presentation - 2020 Full Year Results
2020Clinuvel Pharmaceuticals Limited Announces Dividend for the Full Year Ended J..
2020CLINUVEL PHARMACEUTICALS : Declares Full Year Dividend
2020CLINUVEL PHARMACEUTICALS : Full Year Results
2020CLINUVEL PHARMACEUTICALS : Appendix 4E and Preliminary Financial Report
2020Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Full Year E..
2020CLINUVEL PHARMACEUTICALS : Appendix 4C – quarterly
2020CLINUVEL PHARMACEUTICALS : Corporate Update
1  2  3  4  5Volgende
Volgende evenement op CLINUVEL PHARMACEUTICALS LIMITED
30/07/21
Komende gebeurtenissen in de sector